CervoMed (CRVO) Interest Coverage Ratio (2010 - 2026)
CervoMed (CRVO) posted Interest Coverage Ratio of 24727.21 for Q1 2026, down 30.95% sequentially from 18883.1 in Q3 2025, and down 267.91% YoY from 14726.59 in Q1 2025.
CervoMed (CRVO) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
CervoMed has reported Interest Coverage Ratio for 17 years, with the latest figure at 24727.21 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 267.91% year-over-year to 24727.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 94824.75 (down 257.37% YoY) and the FY2024 annual result came in at 6547.1, down 29928.41% from the prior year.
- Interest Coverage Ratio eased to 24727.21 in Q1 2026 per CRVO's latest filing, from 18883.1 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 60.91 in Q4 2022 and troughed at 24727.21 in Q1 2026.
- A 5-year average of 4661.05 and a median of 279.06 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio jumped 36529.78% in 2022, then plunged 37473.65% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 60.91 in 2022, then plunged by 111.36% to 6.92 in 2023, then tumbled by 37473.65% to 2600.87 in 2024, then tumbled by 626.03% to 18883.1 in 2025, then sank by 30.95% to 24727.21 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 24727.21, 18883.1, and 1295.02 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | CervoMed | 26.12 Mn | 26.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -247,353.74 |
| Mar 31, 2026 | -24,727.21 |
| Sep 30, 2025 | -18,883.10 |
| Jun 30, 2025 | -1,295.02 |
| Mar 31, 2025 | -6,721.02 |
| Dec 31, 2024 | -2,600.87 |
| Sep 30, 2024 | -10,337.69 |
| Jun 30, 2024 | -130.18 |
| Dec 31, 2023 | -6.92 |
| Jun 30, 2023 | -34.54 |
| Mar 31, 2023 | -427.94 |
| Dec 31, 2022 | 60.91 |
| Sep 30, 2022 | -10.40 |
| Jun 30, 2022 | -49.02 |
| Mar 31, 2022 | -91.72 |
| Dec 31, 2021 | -0.17 |
| Sep 30, 2021 | -264.46 |
| Jun 30, 2021 | -17.48 |
| Mar 31, 2021 | -151.11 |
| Dec 31, 2020 | -0.27 |